In one case, a fake email login page designed to steal passwords was sent in April to a top Gilead executive involved in legal and corporate affairs.
Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)ByREUTERS
